Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Abstract 5555: Pharmacogenetics-pharmacokinetics study of bevacizumab in mCRC patients treated with Avastin-Folfiri regimen: Search for predictive markers of response and study of the pharmacokinetics variability

Anne-Sophie Chantry, Joseph Ciccolini, Camille Sibertin-Blanc, Laetitia Dahan, Sylviane Olschwang, Jean-François Seitz, Bruno Lacarelle

Cancer Res (2014) 74 (19_Supplement): 5555.

https://doi.org/10.1158/1538-7445.AM2014-5555

Published: 01 October 2014

View article titled, Abstract 5555: Pharmacogenetics-pharmacokinetics study of bevacizumab in mCRC patients treated with Avastin-Folfiri regimen: Search for predictive markers of response and study of the pharmacokinetics variability

Journal Articles

Abstract 5065: Gene expression profiling of colon adenocarcinomas reveals six prototypic molecular subtypes with distinct clinical and molecular characteristics

Laetitia Marisa, Laure Vescovo, Aurélien Reyniès, Alex Duval, Marie-Christine Etienne-Grimaldi, Marie-Pierre Gaub, Dominique Guenot, Sylvain Kirzin, Gérard Milano, Sylviane Olschwang, Janick Selves, Pierre Laurent-Puig, Valérie Boige

Cancer Res (2012) 72 (8_Supplement): 5065.

https://doi.org/10.1158/1538-7445.AM2012-5065

Published: 15 April 2012

View article titled, Abstract 5065: Gene expression profiling of colon adenocarcinomas reveals six prototypic molecular subtypes with distinct clinical and molecular characteristics

Journal Articles

MSH2 in Contrast to MLH1 and MSH6 Is Frequently Inactivated by Exonic and Promoter Rearrangements in Hereditary Nonpolyposis Colorectal Cancer

Françoise Charbonnier, Sylviane Olschwang, Qing Wang, Cécile Boisson, Cosette Martin, Marie-Pierre Buisine, Alain Puisieux, Thierry Frebourg

Cancer Res (2002) 62 (3): 848–853.

Published: 01 February 2002

View article titled, MSH2 in Contrast to MLH1 and MSH6 Is Frequently Inactivated by Exonic and Promoter Rearrangements in Hereditary Nonpolyposis Colorectal Cancer

Journal Articles

Detection of Exon Deletions and Duplications of the Mismatch Repair Genes in Hereditary Nonpolyposis Colorectal Cancer Families Using Multiplex Polymerase Chain Reaction of Short Fluorescent Fragments

Françoise Charbonnier, Grégory Raux, Qing Wang, Nathalie Drouot, Frédéric Cordier, Jean-Marc Limacher, Jean-Christophe Saurin, Alain Puisieux, Sylviane Olschwang, Thierry Frebourg

Cancer Res (2000) 60 (11): 2760–2763.

Published: 01 June 2000

View article titled, Detection of Exon Deletions and Duplications of the Mismatch Repair Genes in Hereditary Nonpolyposis Colorectal Cancer Families Using Multiplex Polymerase Chain Reaction of Short Fluorescent Fragments

Journal Articles

Concerted Nonsyntenic Allelic Losses in Hyperploid Hepatocellular Carcinoma as Determined by a High-Resolution Allelotype

Valérie Boige, Pierre Laurent-Puig, Pierre Fouchet, Jean François Fléjou, Geneviève Monges, Pierre Bedossa, Paulette Bioulac-Sage, Frédérique Capron, Anette Schmitz, Sylviane Olschwang, Gilles Thomas

Cancer Res (1997) 57 (10): 1986–1990.

Published: 01 May 1997

View article titled, Concerted Nonsyntenic Allelic Losses in Hyperploid Hepatocellular Carcinoma as Determined by a High-Resolution Allelotype

NARROW

Abstract 5555: Pharmacogenetics-pharmacokinetics study of bevacizumab in mCRC patients treated with Avastin-Folfiri regimen: Search for predictive markers of response and study of the pharmacokinetics variability

Abstract 5065: Gene expression profiling of colon adenocarcinomas reveals six prototypic molecular subtypes with distinct clinical and molecular characteristics

MSH2 in Contrast to MLH1 and MSH6 Is Frequently Inactivated by Exonic and Promoter Rearrangements in Hereditary Nonpolyposis Colorectal Cancer

Detection of Exon Deletions and Duplications of the Mismatch Repair Genes in Hereditary Nonpolyposis Colorectal Cancer Families Using Multiplex Polymerase Chain Reaction of Short Fluorescent Fragments

Concerted Nonsyntenic Allelic Losses in Hyperploid Hepatocellular Carcinoma as Determined by a High-Resolution Allelotype

Email alerts

AACR Journals

Abstract 5555: Pharmacogenetics-pharmacokinetics study of bevacizumab in mCRC patients treated with Avastin-Folfiri regimen: Search for predictive markers of response and study of the pharmacokinetics variability

Abstract 5065: Gene expression profiling of colon adenocarcinomas reveals six prototypic molecular subtypes with distinct clinical and molecular characteristics

MSH2 in Contrast to MLH1 and MSH6 Is Frequently Inactivated by Exonic and Promoter Rearrangements in Hereditary Nonpolyposis Colorectal Cancer

Detection of Exon Deletions and Duplications of the Mismatch Repair Genes in Hereditary Nonpolyposis Colorectal Cancer Families Using Multiplex Polymerase Chain Reaction of Short Fluorescent Fragments

Concerted Nonsyntenic Allelic Losses in Hyperploid Hepatocellular Carcinoma as Determined by a High-Resolution Allelotype

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only